These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12084472)

  • 1. Targeting critical regions in genomic DNA with AT-specific anticancer drugs.
    Woynarowski JM
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):300-8. PubMed ID: 12084472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-specific DNA damage by AT-specific DNA-reactive drugs is predicted by drug binding specificity.
    Woynarowski JM; Napier C; Trevino AV; Arnett B
    Biochemistry; 2000 Aug; 39(32):9917-27. PubMed ID: 10933811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genome factor in region-specific DNA damage: the DNA-reactive drug U-78779 prefers mixed A/T-G/C sequences at the nucleotide level but is region-specific for long pure AT islands at the genomic level.
    Herzig MC; Rodriguez KA; Trevino AV; Dziegielewski J; Arnett B; Hurley L; Woynarowski JM
    Biochemistry; 2002 Feb; 41(5):1545-55. PubMed ID: 11814348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT-rich islands in genomic DNA as a novel target for AT-specific DNA-reactive antitumor drugs.
    Woynarowski JM; Trevino AV; Rodriguez KA; Hardies SC; Benham CJ
    J Biol Chem; 2001 Nov; 276(44):40555-66. PubMed ID: 11487576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tallimustine lesions in cellular DNA are AT sequence-specific but not region-specific.
    Herzig MC; Trevino AV; Arnett B; Woynarowski JM
    Biochemistry; 1999 Oct; 38(42):14045-55. PubMed ID: 10529251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs.
    Woynarowski JM; Krugliak M; Ginsburg H
    Mol Biochem Parasitol; 2007 Jul; 154(1):70-81. PubMed ID: 17524501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DNA minor groove-alkylating cyclopropylpyrroloindole drugs adozelesin and bizelesin induce different DNA damage response pathways in human colon carcinoma HCT116 cells.
    Cao PR; McHugh MM; Melendy T; Beerman T
    Mol Cancer Ther; 2003 Jul; 2(7):651-9. PubMed ID: 12883038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bizelesin (U-77779), a bifunctional alkylating minor groove agent, on genomic and simian virus 40 DNA.
    Woynarowski JM; McHugh MM; Gawron LS; Beerman TA
    Biochemistry; 1995 Oct; 34(40):13042-50. PubMed ID: 7548063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of DNA alkylation sites induced by adozelesin and bizelesin in human cells by ligation-mediated polymerase chain reaction.
    Lee CS; Pfeifer GP; Gibson NW
    Biochemistry; 1994 May; 33(19):6024-30. PubMed ID: 8180230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AT islands - their nature and potential for anticancer strategies.
    Woynarowski JM
    Curr Cancer Drug Targets; 2004 Mar; 4(2):219-34. PubMed ID: 15032671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix attachment region (MAR) properties and abnormal expansion of AT island minisatellites in FRA16B fragile sites in leukemic CEM cells.
    Jackson JA; Trevino AV; Herzig MC; Herman TS; Woynarowski JM
    Nucleic Acids Res; 2003 Nov; 31(21):6354-64. PubMed ID: 14576323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in sequence selective minor groove DNA effectors.
    Reddy BS; Sharma SK; Lown JW
    Curr Med Chem; 2001 Apr; 8(5):475-508. PubMed ID: 11281837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA minor groove alkylating agents.
    Denny WA
    Curr Med Chem; 2001 Apr; 8(5):533-44. PubMed ID: 11281840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity of the cyclopropylpyrroloindole compounds adozelesin, bizelesin and carzelesin in a human tumor colony-forming assay.
    Hidalgo M; Izbicka E; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD
    Anticancer Drugs; 1999 Mar; 10(3):295-302. PubMed ID: 10327036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of AT-specific DNA-interstrand crosslinks by bizelesin in genomic and simian virus 40 DNA.
    Woynarowski JM; Chapman WG; Napier C; Herzig MC
    Biochim Biophys Acta; 1999 Feb; 1444(2):201-17. PubMed ID: 10023060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-minor-groove alkylators, a new class of anticancer agents.
    D'Incalci M
    Ann Oncol; 1994 Dec; 5(10):877-8. PubMed ID: 7696158
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of bizelesin (U-77,779), a bifunctional alkylating minor groove binder, on replication of genomic and simian virus 40 DNA in BSC-1 cells.
    Woynarowski JM; Beerman TA
    Biochim Biophys Acta; 1997 Jul; 1353(1):50-60. PubMed ID: 9256064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective DNA interaction of the novel distamycin derivative FCE 24517.
    Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
    Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065.
    Walker DL; Reid JM; Ames MM
    Cancer Chemother Pharmacol; 1994; 34(4):317-22. PubMed ID: 8033298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulative interplay of two adozelesin molecules with d(ATTAAT)â‚‚achieving ligand-stacked Watson-Crick and Hoogsteen base-paired duplex adducts.
    Hopton SR; Thompson AS
    Biochemistry; 2011 May; 50(19):4143-54. PubMed ID: 21469674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.